Literature DB >> 9018114

A role for epidermal growth factor receptor, c-Src and focal adhesion kinase in an in vitro model for the progression of colon cancer.

V G Brunton1, B W Ozanne, C Paraskeva, M C Frame.   

Abstract

We have examined the function of the epidermal growth factor (EGF) receptor, c-Src and focal adhesion kinase (FAK) in the progression of colon cancer using an in vitro progression model. A non-tumorigenic cell line was derived from a premalignant colonic adenoma (PC/AA) from which a clonogenic variant was established (AA/C1). Following sequential treatment with sodium butyrate and the carcinogen N-methyl-N'-nitro-N-nitro-soguanidine an anchorage-independent line was isolated which, with time in culture, became tumorigenic when injected into athymic nude mice (AA/C1/SB10). We have shown that both EGF receptor and FAK protein levels were elevated in the carcinoma cells as compared to the adenoma cells, while the expression and activity of c-Src were unaltered during the adenoma to carcinoma transition. EGF induced the movement of the carcinoma cells into a reconstituted basement membrane which was not seen with the premalignant adenoma cells. This increased motility was accompanied by an EGF-induced increase in c-Src kinase activity, relocalisation of c-Src to the cell periphery and phosphorylation of FAK in the carcinoma cells but not in the adenoma cells. This suggests that c-Src plays a role in the biological behaviour of colonic carcinoma cells induced by migratory factors such as EGF, perhaps acting in conjunction with FAK to regulate focal adhesion turnover and tumour cell motility. Furthermore, although c-Src has been implicated in colonic tumour progression, we demonstrate here that in the adenoma to carcinoma in vitro model c-Src is not the driving force for this progression but co-operates with other molecules in carcinoma development.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9018114     DOI: 10.1038/sj.onc.1200827

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  32 in total

1.  Combined inhibition of c-Src and epidermal growth factor receptor abrogates growth and invasion of head and neck squamous cell carcinoma.

Authors:  Priya Koppikar; Seung-Ho Choi; Ann Marie Egloff; Quan Cai; Shinsuke Suzuki; Maria Freilino; Hiroshi Nozawa; Sufi M Thomas; William E Gooding; Jill M Siegfried; Jennifer R Grandis
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

2.  Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer.

Authors:  Yekaterina Y Zaytseva; Piotr G Rychahou; Pat Gulhati; Victoria A Elliott; William C Mustain; Kathleen O'Connor; Andrew J Morris; Manjula Sunkara; Heidi L Weiss; Eun Y Lee; B Mark Evers
Journal:  Cancer Res       Date:  2012-01-19       Impact factor: 12.701

Review 3.  Emerging anticancer therapeutic targets and the cardiovascular system: is there cause for concern?

Authors:  Xuyang Peng; Laura Pentassuglia; Douglas B Sawyer
Journal:  Circ Res       Date:  2010-04-02       Impact factor: 17.367

4.  Extracellular domain dependence of PTPalpha transforming activity.

Authors:  Barbara Tremper-Wells; Ross J Resnick; Xinmin Zheng; Leslie J Holsinger; David Shalloway
Journal:  Genes Cells       Date:  2010-06-07       Impact factor: 1.891

Review 5.  The SRC family of protein tyrosine kinases: a new and promising target for colorectal cancer therapy.

Authors:  Christopher Lieu; Scott Kopetz
Journal:  Clin Colorectal Cancer       Date:  2010-04       Impact factor: 4.481

6.  The protrusive phase and full development of integrin-dependent adhesions in colon epithelial cells require FAK- and ERK-mediated actin spike formation: deregulation in cancer cells.

Authors:  V G Brunton; V J Fincham; G W McLean; S J Winder; C Paraskeva; J F Marshall; M C Frame
Journal:  Neoplasia       Date:  2001 May-Jun       Impact factor: 5.715

7.  Therapeutic IMC-C225 antibody inhibits breast cancer cell invasiveness via Vav2-dependent activation of RhoA GTPase.

Authors:  Poonam R Molli; Liana Adam; Rakesh Kumar
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

8.  Inhibition of focal adhesion kinase and src increases detachment and apoptosis in human neuroblastoma cell lines.

Authors:  Elizabeth A Beierle; Xiaojie Ma; Angelica Trujillo; Elena V Kurenova; William G Cance; Vita M Golubovskaya
Journal:  Mol Carcinog       Date:  2010-03       Impact factor: 4.784

9.  Targeting SRC and epidermal growth factor receptor in colorectal cancer: rationale and progress into the clinic.

Authors:  Scott Kopetz
Journal:  Gastrointest Cancer Res       Date:  2007

10.  The actin-bundling protein fascin is overexpressed in colorectal adenomas and promotes motility in adenoma cells in vitro.

Authors:  D Qualtrough; K Singh; N Banu; C Paraskeva; M Pignatelli
Journal:  Br J Cancer       Date:  2009-09-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.